Vaccines, blood, antisera, toxins and cultures in   Dominican Republic

Exports In 2023, Dominican Republic exported $1.08M in Vaccines, blood, antisera, toxins and cultures, making it the 100th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 315th most exported product in Dominican Republic. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Dominican Republic are: United States ($648k), Guatemala ($413k), Germany ($4.8k), Spain ($4.62k), and Costa Rica ($2.97k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Dominican Republic between 2022 and 2023 were United States ($638k), Costa Rica ($2.97k), and Panama ($860).

Imports In 2023, Dominican Republic imported $104M in Vaccines, blood, antisera, toxins and cultures, becoming the 89th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 65th most imported product in Dominican Republic. Dominican Republic imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($27M), Costa Rica ($19.2M), Germany ($11.7M), Belgium ($10.8M), and China ($3.63M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Dominican Republic between 2022 and 2023 were United States ($9.35M), Costa Rica ($4.95M), and Belgium ($3.71M).